http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112018013084-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
filingDate 2017-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aa6eb3d971d69ed58a1c529dc0937b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf874230780a0cfe3acee9fcda6faca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3819fae7b28b67d3f9b85670dd5f7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e6b0be4f59b1fa2d30e6ff666c51b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fbc44074c753a30be1b06a502c0ab2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d94053eb8934524fc63040791989b9d
publicationDate 2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112018013084-A2
titleOfInvention combination treatments comprising administration of imidazopyrazinones
abstract The present invention provides combination treatments comprising administering compounds that are inhibitors of the pde1 enzyme and other compounds useful in the treatment of neurodegenerative disorders, such as, for example, Alzheimer's disease, Parkinson's disease or Huntington's disease. Separate aspects of the invention are directed to the combined use of said compounds for the treatment of neurodegenerative and / or cognitive disorders. The present invention also provides pharmaceutical compositions comprising said pde1 enzyme inhibitors together with other compounds useful in the treatment of neurodegenerative disorders.
priorityDate 2016-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411299155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21140198

Total number of triples: 35.